At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 50 enrolled
Drug / intervention
Neostigmine with glycopyrrolate +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Postoperative Urinary Retention in Patients After Noncardiac Surgery and Reversal of Neuromuscular Block by Neostigmine or Sugammadex: A Randomized Controlled Trial
In Brief
A Phase 4 clinical trial evaluating Neostigmine with glycopyrrolate and Sugammadex for Neuromuscular Blockade. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The investigators propose a randomized trial comparing sugammadex and neostigmine for the reversal of neuromuscular blocks induced by rocuronium or vecuronium in adults having general anesthesia with muscular block for noncardiac surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeuromuscular Blockade
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2023202420252026
First PostedSep 2022
Enrollment StartDec 2023
Primary CompletionAug 2024
TodayJul 2026
First PostedSep 19, 2022
Enrollment StartDec 1, 2023
Primary CompletionAug 7, 2024
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 3.8 years ago
Interventions
Neostigmine with glycopyrrolatedrug
Administration by intravenous infusion
Sugammadexdrug
Administration by intravenous infusion